Diabetes Remote Intervention to improVe Use of Evidence-based Medications

NCT06046560 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Cardiovascular Diseases
Diabetes

Interventions

DRUG: SGLT2 inhibitor, GLP-1 RA
BEHAVIORAL: Education-First

Sponsor

Brigham and Women's Hospital

Collaborators

[object Object]